UPC_APP_17607/2025

RSV F PROTEIN COMPOSITIONS AND METHODS FOR MAKING SAME

Prozessuale & UnteranträgeRücknahmeanträgeMilan CDApplication Rop 265—Vergleich erfolgt: Vor Hauptsache

2025-04-22ZurückgenommenproceduralApplication Rop 265
The Milan Central Division allowed Pfizer's withdrawal of both the revocation action (ACT_45928/2024) and the counterclaim for revocation (CC_60908/2024) against GlaxoSmithKline Biologicals SA concerning EP 4 183 412 (RSV vaccine patent), with GSK's consent and without a cost decision; 60% of court fees were reimbursed to Pfizer.